Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1998
05/26/1998US5756810 Process of preparing 3-nitro benzoate compounds in lower alkanol
05/26/1998US5756782 Suspending diacetylrhein in an organic solvent and water mixture, adding tertiary amine, then adding to the solution obtained, an caraboxylic acid salt of alkali or alkaline metals, hydrolyzing, collecting pure product by filtration
05/26/1998US5756776 Semi-synthetic taxanes with anti-tumoural activity
05/26/1998US5756765 2- (2-Substituted pyrrolidin-4-yl) thio-carbapenem derivatives
05/26/1998US5756764 Drug; proteasome inhibitors
05/26/1998US5756761 Preparing hot saturated aqueous solutions of at least two different amino acids, one polar hydrophilic and another nonpolar hydrophobic, mixing, drying
05/26/1998US5756745 Preparation of nalbuphine having low levels of β-epimer
05/26/1998US5756743 Spiro cyclopent b!indole-piperidines!
05/26/1998US5756737 Process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine
05/26/1998US5756734 Crambescidins: new antiviral and cytotoxic compounds from the sponge crambe crambe
05/26/1998US5756733 Vitamin D amide derivatives
05/26/1998US5756732 Substituted heteroarylphenyloxazolidinones
05/26/1998US5756723 Metal-mediated cross-coupling with ring-metalated porphyrins
05/26/1998US5756718 Anti-endotoxin compounds
05/26/1998US5756711 Viricides
05/26/1998US5756706 Chemical intermediates
05/26/1998US5756669 Mutants
05/26/1998US5756550 Method of treatment of parkinson's disease
05/26/1998US5756549 Renin inhibitors
05/26/1998US5756548 Treatment of parkinson*s disease
05/26/1998US5756547 Method for the treatment of preserving organs or tissue for transplantation
05/26/1998US5756546 Water-soluble nimesulide salt and its preparation, aqueous dolution containing it, nimesulide-based combinations and their uses
05/26/1998US5756545 Antiarthritic agents; osteoporosis
05/26/1998US5756544 Carboxyalkylethers, formulations, and treatment of vascular diseases
05/26/1998US5756543 Bitterness-relieving agent
05/26/1998US5756541 Irridiating target ocular tissue of patient with laser radiation, wherein the patient has been administered with porphyrins photoactive drugs which absorb the wavelength of the radiation, repetation of tratement increase visual acuity
05/26/1998US5756540 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
05/26/1998US5756539 Such as depression, loss of cognitive function, mood swings, anxiety; administering orally or as a dermal implant
05/26/1998US5756538 Reducing the sedative and relaxant side effect
05/26/1998US5756537 Regime for paclitaxel in Kaposi's sarcoma patients
05/26/1998US5756535 Antiarrhythmia agents; antiischemic agents; cell antiproliferative agents
05/26/1998US5756534 Retroviral protease inhibitors
05/26/1998US5756533 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/26/1998US5756532 Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
05/26/1998US5756530 3,4-substituted pyrazoles for the treatment of inflammation
05/26/1998US5756529 Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
05/26/1998US5756525 Using a thiazolidinedione compound
05/26/1998US5756524 Applying to combat cytopathogenic fungi
05/26/1998US5756520 Compounds with analgesic and local anaesthetic effect
05/26/1998US5756519 Fibrinogen receptor antagonists
05/26/1998US5756515 Brain disorders; nervous system disorders
05/26/1998US5756514 Opioid side-effect reduction
05/26/1998US5756513 Adjustment of the prolactin cycle
05/26/1998US5756512 Treatment of non-small cell lung carcinoma
05/26/1998US5756511 Method for treating symptoms of a neurodegenerative condition
05/26/1998US5756510 Potentiate effects of cytotoxic drugs or radiotherapy
05/26/1998US5756506 Single high dose fluoroquinolone treatment
05/26/1998US5756505 N-acylpiperazine derivative, antibacterial drug and anti-ulcer drug
05/26/1998US5756504 Tocolytic oxytocin receptor antagonists
05/26/1998US5756503 Analgesics, anesthetics, antiinflammatory agents
05/26/1998US5756499 Substituted imidazole compounds
05/26/1998US5756496 Drugs for treating central nervous system disorder
05/26/1998US5756495 Nervous system disorders; alzheimer's disease
05/26/1998US5756494 Protein kinase inhibitors for treatment of neurological disorders
05/26/1998US5756493 Active against methicillin resistant bacteria
05/26/1998US5756492 Graft survival prolongation with porphyrins
05/26/1998US5756491 Antiviral cobalt-organic compounds
05/26/1998US5756490 Estrogen and gestagen
05/26/1998US5756489 18,19-dinor-vitamin D compounds
05/26/1998US5756488 Comprising (20s,22r)-22-methyl-1alpha,25-dihydroxyvitamin d3
05/26/1998US5756487 Use of salicyclic acid for regulating skin wrinkles and or skin atrophy
05/26/1998US5756486 Cyclized nucleotide; viricide
05/26/1998US5756485 Silicone-containing derivatives of salicylic acid which have desquamating properties
05/26/1998US5756483 Pharmaceutical compositions for intranasal administration of apomorphine
05/26/1998US5756481 Cysteine
05/26/1998US5756478 Treating cancer while reducing toxicity associated with the administration of conventional ''D'' nucleoside drugs such as AZT, by coadministering ''L'' nucleoside compounds such as Beta-L-2',3'-dideoxy-2',3'-didehydrocytidine; AIDS
05/26/1998US5756477 Treatment of aids with complex of poly (A). poly (U)
05/26/1998US5756473 6-O-methyl erythromycin D and process for making
05/26/1998US5756471 Use of a sophorolipid to provide free radical formation inhibiting activity or elastase inhibiting activity
05/26/1998US5756469 Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
05/26/1998US5756466 Inhibitors of interleukin-1β converting enzyme
05/26/1998US5756464 Therapeutic uses of BPI protein products in humans with hemmorhage due to trauma
05/26/1998US5756453 Use of angiogenic lipids for vascularizing tissue
05/26/1998US5756349 Culture of cells and radioimmunoassay
05/26/1998US5756318 Polysaccharides and preparation thereof
05/26/1998US5756310 Culture product
05/26/1998US5756264 Expression vector systems and method of use
05/26/1998US5756125 Immediate and delayed analgesic therapy
05/26/1998US5756121 Forming liposomes for treatment of drug resistant bacteria
05/26/1998US5756119 Aqueous carrier containing active ingredient, nonionic polyacrylamide predispersed in water-immiscible oil containing surfactant
05/26/1998US5756118 Enhanced skin penetration system for improved topical delivery of drugs
05/26/1998US5756116 Nucleoside phosphate therapy for viral infection
05/26/1998US5756092 Use, in a composition, as cyclooxygenase activator and/or stabilizer, of at least one pyrimidine derivative sustituted at the 6th position and a cyclooxygenase substrate
05/26/1998US5756090 Oxygen activatable formulations for disinfection or sterilization
05/26/1998US5756071 Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier
05/26/1998US5755968 Dialysis system and method for removing toxic matter from the serum of the large intestine
05/26/1998US5755237 Intravenous injection
05/26/1998CA2136823C Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism
05/26/1998CA2113360C Stable, anti-corrosive peracetic/peroxide sterilant
05/26/1998CA2057444C Substituted pyridyl-dihydroxy-heptenoic acid and its salts
05/26/1998CA2056670C Therapeutic agent for glaucoma
05/26/1998CA2052073C Sulfonamide fibrinogen receptor antagonists
05/26/1998CA2044484C Hexahydroazepine derivatives, a process for their preparation and pharmaceutical compositions containing them
05/25/1998CA2215929A1 Novel lep
05/22/1998WO1998021359A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998WO1998021345A1 Hsv/aav hybrid amplicon vectors
05/22/1998WO1998021331A1 Human breast tumor-specific proteins
05/22/1998WO1998021327A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
05/22/1998WO1998021243A1 Method and novel compounds for use therein
05/22/1998WO1998021228A1 Tissue specific expression of retinoblastoma protein
1 ... 6650 6651 6652 6653 6654 6655 6656 6657 6658 6659 6660 6661 6662 6663 6664 6665 6666 6667 6668 6669 6670 ... 7860